FibroGen Company
FibroGen, a research-based biotech firm, uses its expertise CTGF and HIF biology to discover, develop, and commercialize novel therapeutics.
Investors
(Reupload).png)
(Reupload).png)
Technology:
Drug Delivery
Industry:
Small&Large Molecules
Headquarters:
San Francisco, California, United States
Founded Date:
1993
Employees Number:
251-500
Funding Status:
IPO
Estimated Revenue:
$10M to $50M
Register and Claim Ownership